NASDAQ: UTHR · Health Care / Biotechnology: Pharmaceutical Preparations

United Therapeutics Corporation

How United Therapeutics Corporation compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap
$25.5B
Price
$593.54
P/E
19.3
EPS (TTM)
$30.72
1-year return
30.9%
Dividend yield
0.0%
52-week range
$437.33–$596.76

Compared with

For information only, not investment advice. Data may contain errors. Disclaimer · Sources